Pfizer: Why Wall Street Habitually Overestimates Target Price [Seeking Alpha]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Seeking Alpha
Political uncertainties around 'TrumpRx' and 'Most-Favored-Nation' drug pricing models continue to threaten PFE's margins and valuation outlook. PFE's FWD P/E of 9.3x appears attractive on the surface, but is actually not once the multi-year earnings decline risks are factored in. A well-covered 6.27% dividend yield and pipeline progress help to offset the negatives. Looking for a portfolio of ideas like this one? Members of Envision Early Retirement get exclusive access to our subscriber-only portfolios. Learn More » BobHemphill/iStock via Getty Images Pfizer stock: Wall Street loves it again I last covered Pfizer Inc. stock (NYSE: PFE ) on Feb 19. The article rated the stock as hold after examining its FQ4 earnings report (ER) and dividend declarations. Since then, a few new catalysts have More on my IG service As you can tell, our core style is to provide actionable and unambiguous ideas from our independent research. If your share this investment style, check out
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Jim Cramer on Pfizer: “I Just Need to Know Their Product Flow Better” [Yahoo! Finance]Yahoo! Finance
- Consecutive approvals of Opdivo for Hodgkin's lymphoma to boost sales growth [Yahoo! Finance]Yahoo! Finance
- ????????????? - ??????????????????2026-2035? [CNET News]CNET News
- Guggenheim Sees Favorable Risk-Reward for Pfizer (PFE) Ahead of Phase 3 Data [Yahoo! Finance]Yahoo! Finance
- Income Investors Face a Hard Truth About Pfizer's Payout Safety [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 2/3/26 - Beat
PFE
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/16/26 - Form 4
- 3/12/26 - Form ARS
- PFE's page on the SEC website